New UH Cancer Center Coordinated Liver Cancer Clinical Trial Opens Only in Hawai'i
November 14, 2019
November 14, 2019
HONOLULU, Hawaii, Nov. 14 -- The University of Hawaii Cancer Center issued the following news:
A new University of Hawai'i Cancer Center coordinated liver cancer clinical trial opened in Hawai'i combining two different immunotherapy medications to combat the aggressive disease. The Phase II clinical trial is only available in Hawai'i, a state with one of the highest incidence and mortality rates of liver cancer in the U.S.
"Many patients with liver c . . .
A new University of Hawai'i Cancer Center coordinated liver cancer clinical trial opened in Hawai'i combining two different immunotherapy medications to combat the aggressive disease. The Phase II clinical trial is only available in Hawai'i, a state with one of the highest incidence and mortality rates of liver cancer in the U.S.
"Many patients with liver c . . .